278 related articles for article (PubMed ID: 10022545)
1. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression.
Lo WD; Qu G; Sferra TJ; Clark R; Chen R; Johnson PR
Hum Gene Ther; 1999 Jan; 10(2):201-13. PubMed ID: 10022545
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.
Clark KR; Sferra TJ; Lo W; Qu G; Chen R; Johnson PR
J Drug Target; 1999 Dec; 7(4):269-83. PubMed ID: 10682906
[TBL] [Abstract][Full Text] [Related]
3. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.
Siders WM; Shields J; Kaplan J; Lukason M; Woodworth L; Wadsworth S; Scaria A
Hum Gene Ther; 2009 Jan; 20(1):11-20. PubMed ID: 18828728
[TBL] [Abstract][Full Text] [Related]
5. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice.
Snyder RO; Spratt SK; Lagarde C; Bohl D; Kaspar B; Sloan B; Cohen LK; Danos O
Hum Gene Ther; 1997 Nov; 8(16):1891-900. PubMed ID: 9382955
[TBL] [Abstract][Full Text] [Related]
6. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
7. Delivery of recombinant adeno-associated virus by jet injection.
Janouskova O; Nellessen T; Stokrova J; Jinoch P; Smahel M
Int J Mol Med; 2003 Nov; 12(5):687-91. PubMed ID: 14532994
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.
Mohan RR; Schultz GS; Hong JW; Mohan RR; Wilson SE
Exp Eye Res; 2003 Mar; 76(3):373-83. PubMed ID: 12573666
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity.
Martino AT; Nayak S; Hoffman BE; Cooper M; Liao G; Markusic DM; Byrne BJ; Terhorst C; Herzog RW
PLoS One; 2009 Aug; 4(8):e6376. PubMed ID: 19652717
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints.
Apparailly F; Khoury M; Vervoordeldonk MJ; Adriaansen J; Gicquel E; Perez N; Riviere C; Louis-Plence P; Noel D; Danos O; Douar AM; Tak PP; Jorgensen C
Hum Gene Ther; 2005 Apr; 16(4):426-34. PubMed ID: 15871674
[TBL] [Abstract][Full Text] [Related]
11. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
12. Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors.
Maeda Y; Ikeda U; Shimpo M; Ueno S; Ogasawara Y; Urabe M; Kume A; Takizawa T; Saito T; Colosi P; Kurtzman G; Shimada K; Ozawa K
J Mol Cell Cardiol; 1998 Jul; 30(7):1341-8. PubMed ID: 9710802
[TBL] [Abstract][Full Text] [Related]
13. Recombinant AAV-mediated gene delivery to the central nervous system.
Tenenbaum L; Chtarto A; Lehtonen E; Velu T; Brotchi J; Levivier M
J Gene Med; 2004 Feb; 6 Suppl 1():S212-22. PubMed ID: 14978764
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
15. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
Le HT; Yu QC; Wilson JM; Croyle MA
J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
[TBL] [Abstract][Full Text] [Related]
16. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.
Goater J; Müller R; Kollias G; Firestein GS; Sanz I; O'Keefe RJ; Schwarz EM
J Rheumatol; 2000 Apr; 27(4):983-9. PubMed ID: 10782827
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
18. Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain.
Mastakov MY; Baer K; Symes CW; Leichtlein CB; Kotin RM; During MJ
J Virol; 2002 Aug; 76(16):8446-54. PubMed ID: 12134047
[TBL] [Abstract][Full Text] [Related]
19. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors.
Svensson EC; Marshall DJ; Woodard K; Lin H; Jiang F; Chu L; Leiden JM
Circulation; 1999 Jan; 99(2):201-5. PubMed ID: 9892583
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.
Grant CA; Ponnazhagan S; Wang XS; Srivastava A; Li T
Curr Eye Res; 1997 Sep; 16(9):949-56. PubMed ID: 9288458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
